Viewing data from:

MIDAZOLAM HYDROCHLORIDE

ANDA

MIDAZOLAM HYDROCHLORIDE | A075873 | HIKMA PHARMACEUTICALS USA INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.6871

per ml

Lowest NADAC/Unit

$0.6871

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00054356699MIDAZOLAM HCL 2 MG/ML SYRUP	$0.6871	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$157.42

Highest Price

$182.40

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
68094-0762-62MIDAZOLAM HCL 2MG/ML SYRUP	$157.42	FSS	Golden State Medical Supply, Inc.	06/14/2028
68094-0764-62MIDAZOLAM HCL 2MG/ML SYRUP	$182.40	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain1 active DMF

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

CAMBREX PROFARMACO MILANO SRLMIDAZOLAM HYDROCHLORIDE

DMF 399912024

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 10, 2003	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 2MG BASE/ML

0 patents0 exclusivities▴

SYRUP;ORAL | Approved: Apr 30, 2002

No patent or exclusivity listings for this strength.